Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $5.60, $0.11 better than the analyst estimate of $5.49. Revenue for the quarter came in at $9.27 billion versus the consensus estimate of $8.77 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2021 EPS of $22.07, versus the consensus of $22.12. Thermo Fisher Scientific sees FY2021 revenue of $35.9 billion, versus the consensus of $35.66 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.